What Is Globus Medical, Inc. (GMED) Worth in 2026?
According to the CirclFi Deep Alpha Valuation Engine, Globus Medical, Inc.'s intrinsic value is estimated at $53.51, suggesting the stock is overvalued at its current price of $79.72. With 11 out of 13 models flagging downside (-32.9% average return), the market may be pricing in unsustainable growth. The most optimistic model, Regime Cross, places fair value at $109.71 (+37.6%), while Dynamic NAV — the most conservative — estimates $15.58 (-80.5%). This +118.1% gap reflects genuine analytical uncertainty about Globus Medical, Inc.'s intrinsic worth.
What Do the Models Say About GMED?
13 of 13 models are currently active for GMED. Of these, 1 model suggests upside while 12 models suggest overvaluation. The Bayesian DCF estimates GMED's intrinsic value at $46.30, implying -41.9% downside from the current price. See which stocks rank higher →
How Does GMED Rank in Surgical & Medical Instruments & Apparatus?
Among 111 Surgical & Medical Instruments & Apparatus stocks, GMED ranks #8 by Quality of Company score. CirclFi's QOC score of 9.2/10 evaluates 32 fundamental signals. A score of 9.2 places GMED in the top tier.
See all Most Undervalued Surgical & Medical Instruments & Apparatus Stocks →
Globus Medical, Inc. operates in a competitive landscape where fundamental quality metrics are key differentiators for long-term value creation.
Is GMED a Value Trap?
CirclFi's Value Trap algorithm assigns GMED a score of 19/100 (SAFE). This indicates minimal risk. Fundamentals are healthy. The score cross-references apparent undervaluation against fundamental deterioration signals. Browse lowest value-trap stocks →
Multi-Model Methodology
13 of 13 models are active for Globus Medical, Inc.. Broad coverage provides high confidence. Each model applies a fundamentally different valuation philosophy. See the complete methodology →
According to the CirclFi Quality of Company (QOC) framework, which evaluates 32 signals including margin stability, revenue growth trajectory, leverage, and free cash flow generation, Globus Medical, Inc. is rated at 9.2/10. This elite-tier score ranks among the highest-quality businesses in our coverage universe.
The gap between the most bullish and bearish model spans +118.1% — demonstrating why single-model analysis is dangerous. Browse all stocks with 13-model coverage →
Data Sources & Confidence
Every GMED valuation is built from SEC EDGAR XBRL filings — 700+ standardized financial tags. Macroeconomic context from FRED calibrates discount rates, while GDELT news sentiment feeds into our Sentiment SOTP model. All pipelines run daily. Read the complete data methodology →
Across GMED's 13 active models, average confidence is 44%. Lower confidence may reflect limited history or high volatility.
CirclFi's output is a research starting point, not a buy/sell signal. All data updates daily. Read the full methodology →
Buy with Gumroad